Neoadjuvant Endocrine Therapy Compared With Neoadjuvant Chemotherapy in Premenopausal Patients With ER+, HER2−, Lymph Node+ Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Neoadjuvant Endocrine Therapy Compared With Neoadjuvant Chemotherapy in Pre-Menopausal Patients With Oestrogen Receptor-Positive and HER2-Negative, Lymph Node-Positive Breast Cancer
Breast Cancer Res 2020 May 27;[EPub Ahead of Print], HJ Kim, WC Noh, ES Lee, YS Jung, LS Kim, W Han, SJ Nam, G- Gong, HJ Kim, SH AhnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.